NANEXA AB

No trades
See on Supercharts
Market capitalization
4.575MEUR
−0.0664EUR
−5.226MEUR
255.202KEUR
Beta
0.71

About NANEXA AB

CEO
David Westberg
Website
Headquarters
Uppsala
Employees (FY)
19
Founded
2010
ISIN
SE0007074166
Nanexa AB engages in the development, production, and distribution of medical nanotechnology products. The firm's product, PharmaShell, provides possibilities for drug administration, dosage, and for targeting of parenteral drugs. It also offers Nanexa gas barrier and antifungal coating. The company was founded by Mats Boman, Jan-Otto Carlsson, Christian Östberg, Anders Hårsta, Mårten Rooth, Jessica Östberg, and Anders Johansson in 2007 and is headquartered in Uppsala, Sweden.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Performance
Revenue to profit conversion
Earnings
Next:
‪0‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good

See all brokers